| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |